Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.396
Sell
RSI(14)
46.578
Neutral
STOCH(KDJ)(9,3,3)
49.374
Buy
ATR(14)
0.754
Low Volatility
CCI(14)
-29.613
Neutral
Williams %R
61.750
Sell
TRIX(12,20)
-0.552
Sell
StochRSI(14)
100.000
Buy
Search
Clearpoint Neuro Inc
CLPTAdd to Watchlist
14.940USD
+0.360+2.47%
Close 07-31 16:00（ET）Quotes delayed by 15 min
448.04MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+2.47%
5 Days
+5.81%
1 Month
-20.19%
6 Months
+12.84%
Year to Date
+9.21%
1 Year
+49.40%
Key Figures
14.900Open
14.970High
605.34KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.06%Turnover Ratio
14.580Prev. Close
14.230Low
6.14MTurnover
LossP/E Static
15.66P/B
0.00%Div Yield TTM
-47.08%ROA
30.10052wk High
1.18Volume Ratio
-18.91MNet Profit
29.37MShares
-1.0079EPS TTM
1.30Beta
-149.72%ROE
8.27052wk Low
5.08%Amplitude
63.95%Gross Margin
448.04MMarket Cap
-3.97Reward/Risk
4.79%Risk Rate
TradingKey Stock Score of Clearpoint Neuro Inc
Currency: USD Updated: 2026-07-31Key Insights
Clearpoint Neuro Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 79 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.33.In the medium term, the stock price is expected to trend up.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Clearpoint Neuro Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Clearpoint Neuro Inc Highlights
StrengthsRisks
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 54.34% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 36.97M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 36.97M.
Fairly Valued
The company’s latest PE is -14.82, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 15.83M shares, increasing 10.52% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 124.35K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.02.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
28.333
Target Price
+89.65%
Upside Space
Clearpoint Neuro Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
3
analysts
Buy
Current Rating
28.333
Target Price
+89.65%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Clearpoint Neuro Inc
CLPT
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Indicators
Moving Average
Indicators
Value
Direction
MA5
14.558
Buy
MA10
14.689
Buy
MA20
15.670
Sell
MA50
15.113
Sell
MA100
12.851
Buy
MA200
14.223
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Clearpoint Neuro Inc Info
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
Ticker SymbolCLPT
CompanyClearpoint Neuro Inc
CEOBurnett (Joseph Michael)
Websitehttps://www.clearpointneuro.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52826.200
+448.200 (+0.86%)
28447.600
+286.700 (+1.02%)
7528.400
+53.300 (+0.71%)
14609.000
-140.000 (-0.95%)
63368.000
+516.000 (+0.82%)
6416.100
+50.700 (+0.80%)
79.462
-6.472 (-7.53%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4059.750
+18.320 (+0.45%)
FAQs
What is the current price of Clearpoint Neuro Inc (CLPT)?
The current price of Clearpoint Neuro Inc (CLPT) is 14.94.
What is the symbol of Clearpoint Neuro Inc?
The ticker symbol of Clearpoint Neuro Inc is CLPT.
What is the 52-week high of Clearpoint Neuro Inc?
The 52-week high of Clearpoint Neuro Inc is 30.10.
What is the 52-week low of Clearpoint Neuro Inc?
The 52-week low of Clearpoint Neuro Inc is 8.27.
What is the market capitalization of Clearpoint Neuro Inc?
The market capitalization of Clearpoint Neuro Inc is 448.04M.
Is Clearpoint Neuro Inc (CLPT) currently rated as Buy, Hold, or Sell?
According to analysts, Clearpoint Neuro Inc (CLPT) has an overall rating of Buy, with a price target of 28.33.
What is the Earnings Per Share (EPS TTM) of Clearpoint Neuro Inc (CLPT)?
The Earnings Per Share (EPS TTM) of Clearpoint Neuro Inc (CLPT) is -0.90.